MedTrace Logo

The Exploratory Clinical Trials on the Primary Safety and Effectiveness of High Myopic Posterior Scleral Fixation System

NCT05034016 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-09-05

No results posted yet for this study

Summary

The purpose of this study is to assess the primary safety and efficacy of High Myopic Posterior Scleral Fixation System in the treatment of macular schisis caused by high myopia.

Conditions

  • High Myopia
  • Macular Schisis

Interventions

DEVICE

High Myopic Posterior Scleral Fixation System

Implant HM into the eye through posterior scleral reinforcement

Sponsors & Collaborators

  • GuangZhou WeiShiBo Biotechnology Co., ltd

    lead INDUSTRY

Principal Investigators

  • Wenbing Wei, MD,Ph.D · Beijing Tongren Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2021-12-31
Completion
2022-04-24

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05034016 on ClinicalTrials.gov